In November the U.S. DSCSA legislation comes into force requiring returned pharmaceuticals to be verified. MediLedger offers one of the most popular
DSCSA solutions. Today
MediLedger announced a second solution with a new working group which focuses on the more commercially sensitive area of contracting. Instead of legal compliance, the motive is efficiency and value.
For the contracting solution, MediLedger signed up pharma company
Pfizer, the two biggest U.S. drug wholesalers McKesson and AmerisourceBergen as well as group purchasing organization Premier which represents more than 4,000 hospitals. Other companies are involved but chose not to be part of the announcement.
The contracting and chargeback solution aims to address discounts. Pharmaceutical companies have pricing arrangements with both wholesalers and group purchasing organizations (GPO) which negotiate preferential deals on behalf of large numbers of hospitals.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
